Regeneron Pharmaceuticals Reaches Analyst Target Price
23/8 14:48
In recent trading, shares of Regeneron Pharmaceuticals, Inc. (Symbol: REGN) have crossed above the average analyst 12-month target price of $659.33, changing hands for $663.27/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react:...